Excitotoxic Zn 2+ and Ca 2+ accumulation contributes to neuronal injury after ischemia or prolonged seizures. 
A B S T R A C T
Excitotoxic Zn 2+ and Ca 2+ accumulation contributes to neuronal injury after ischemia or prolonged seizures. accumulation, but markedly exacerbated the consequent dysfunction. 3. Paralleling effects on mitochondria, disruption of buffering and presence of Ca 2+ enhanced Zn 2+ -induced neurodegeneration. 4. Zn 2+ chelation after the high K + /Zn 2+ exposure attenuated both ROS production and neurodegeneration, supporting the potential utility of delayed interventions. Taken together, these data lend credence to the idea that in pathologic states that impair cytosolic Zn 2+ buffering, slow uptake of Zn 2+ along with Ca 2+ into neurons via VSCC can disrupt the mitochondria and induce neurodegeneration.
Introduction
Ischemic stroke is a leading cause of morbidity and mortality to the aging population, but no neuroprotective therapy exists, partly reflecting limited understanding of relevant injury mechanisms. Excitotoxicity, caused by excessive glutamate release, is considered to be a major contributor to neurodegeneration. Prior studies of excitotoxic injury have largely focused on rapid Ca 2+ entry through Nmethyl-D-aspartate (NMDA) receptors, and have suggested mitochondria to be critical targets of the cellular Ca 2+ loads (Choi et al., 1988; Nicholls and Budd, 2000; Rothman and Olney, 1986) , but NMDA receptor targeted therapies have shown limited clinical efficacy (Hoyte et al., 2004; Ikonomidou and Turski, 2002) . Additional studies have implicated another highly prevalent divalent cation, Zn 2+ , which accumulates in neurons after ischemia and prolonged seizures, and contributes to neurodegeneration Koh et al., 1996; Tonder et al., 1990 (Jia et al., 2002; Sensi et al., 1999a; Yin and Weiss, 1995) . Zn 2+ has potent effects on isolated mitochondria (Brown et al., 2000; Dineley et al., 2005; Gazaryan et al., 2007; Jiang et al., 2001; Link and von Jagow, 1995; Sensi et al., 2003; Skulachev et al., 1967) , and neuronal Zn 2+ loading triggered by rapid entry through Ca-AMPA channels induces acute mitochondrial dysfunction, including reactive oxygen species (ROS) generation (Sensi et al., 1999a; Sensi et al., 2000) , with greater potency than Ca 2+ , suggesting that mitochondria might be critical targets of Zn 2+ effects. However, while slower Zn 2+ entry through VSCC caused considerable delayed neurodegeneration, these exposures had relatively little impact on acute mitochondrial function (Sensi et al., 1999a; Weiss et al., 1993) , raising doubt that Zn 2+ translocation contributes importantly to mitochondrial dysfunction in pathological conditions (Pivovarova et al., 2014) .
It is now apparent that in addition to direct entry of extracellular Zn 2+ , another critical determinant of cytosolic (and mitochondrial) Zn 2+ accumulation is the presence of Zn 2+ buffering proteins-like metallothioneins (MTs)-which normally buffer Zn 2+ loads, but can also provide a source from which bound Zn 2+ can be released by oxidative stress/acidosis, as can occur during pathological conditions (Malaiyandi et al., 2004; Maret, 2011; Maret and Vallee, 1998) . Indeed, strong disruption of these intracellular Zn 2+ pools causes acute cytosolic and mitochondrial Zn 2+ accumulation even without Zn 2+ translocation (Sensi et al., 2003) , and can trigger slow Zn 2+ dependent neuronal injury (Aizenman et al., 2000) . However, little is known about the respective contributions of each of these sources to mitochondrial dysfunction; indeed, only few studies to date have begun to explore the idea that the integrity of cytosolic buffering may critically modulate the effects of exogenous Zn 2+ entry on mitochondrial function in cultured neurons (Clausen et al., 2013; Sensi et al., 2003) . Furthermore, as most early studies were carried out in Ca 2+ free media to ensure observation of Zn 2+ specific effects, there is debate about the respective contributions of Ca 2+ and Zn 2+ to mitochondrial dysfunction observed in vivo, with some proposing synergy between these ions (Gazaryan et al., 2007; Jiang et al., 2001; Sensi et al., 2000) while others see little evidence for Zn 2+ contributions (Devinney et al., 2009; Pivovarova et al., 2014 
Material and methods

Ethics statement
This study was carried out in accordance with the recommendations from the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health and approved by the Institutional Animal Care and Use Committee of the University of California, Irvine.
Cortical cultures
Primary mixed cortical cultures were prepared as described previously (Yin et al., 1994) . Briefly, cell suspensions from neocortical regions of CD-1 mouse embryos (gender not determined) from 15 to 16 gestational day timed-pregnant mice (ordered from Charles River Crl:CD1[ICR]) were extracted and plated on astrocytic monolayers in glass-bottomed dishes, on culture treated 24 well microplates, or on Seahorse XF24 cell culture microplates. Cells were maintained in media consisting of Minimum Essential Medium (MEM) supplemented with 10% heat-inactivated horse serum, 10% fetal bovine serum, 2 mM glutamine, and 25 mM glucose, and kept in 37°C/5% CO 2 incubator. 2-3 days after dissection, the cultures were switched to an identical maintenance medium lacking fetal bovine serum and non-neuronal cell division halted by adding 10 μM cytosine arabinoside for 24 h. To prepare glial cultures (used to establish astrocytic monolayers described above), the same protocol was used, except the following: 1) tissues were obtained from 1 to 3 days old postnatal mice (gender not determined), 2) plating media was supplemented with epidermal growth factor (10 ng/ml), and 3) suspensions were directly plated on poly-Dlysine and laminin-coated coverslips and/or tissue culture treated plates.
Reagents and indicators
Hydroethidine (HEt) was purchased from Assay Biotech (Sunnyvale, CA). Newport Green, FluoZin-3 AM, MitoTracker Green, Pluronic F-127, MEM, fetal bovine serum, glutamine, and horse serum were purchased from Life Technologies (Grand Island, NY) . N-methyl-D-aspartate (NMDA), 2,2′-dithiodipyridine (DTDP), Rhodamine 123 (Rhod123), and N,N,N,N-tetrakis(2-pyridylmethyl)ethane-1,2-diamine (TPEN) were purchased from Sigma-Aldrich (St. Louis, MO). Carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP) was purchased from Tocris Bioscience (Ellisville, MO), apocynin obtained from Acros Organics (Morris Plains, NJ), and XF Base Medium (minimal Dulbecco's Modified Eagle's Medium) from Agilent Technologies (Santa Clara, CA). All other chemicals and reagents were purchased from common commercial sources. Ca-AMPA channels to be expressed in a small subset (~13%) of cultured cortical neurons (Yin et al., 1994) , we carried out additional controls using the AMPA channel antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX; 10 μM) during the exposures (Sensi et al., 1999a) , and found no differences.
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Quantitative imaging studies
10-16 days in vitro (DIV) cultures were mounted on the stage of a Nikon Diaphot inverted microscope equipped with a 75 W xenon lamp, a computer-controlled filter wheel, a 40× (1.3 numerical aperture) epifluorescence oil-immersion objective along with a green FITC fluorescence cube (Ex: 480 nm, dichroic: 505 nm, Em: 535 nm) and a red TRITC fluorescence cube (Ex: 540 nm, dichroic: 565 nm, Em: 605 nm). Emitted signals were acquired once every min with a Sensys Photometrics intensified charge-coupled device camera and digitized through the MetaFluor Version 7.0 software (Molecular Devices LLC, Sunnyvale, CA). Camera gain and exposure were adjusted to give baseline maximal fluorescence levels of 200-300 arbitrary units of a maximal 12-bit signal output of 4096 for all fluorophores. While the precise experiment schematic is described below, generally, baseline was measured for 10 min, followed by 10 min pre-treatment with DTDP and/or TPEN (if indicated), then by 5 min Zn 2+ and/or Ca 2+ loading (with high K + ), and finally by wash into HSS, with addition of FCCP if indicated. For imaging, fields with ≥15 healthy looking cells (defined as non-clustered neurons with robust processes), were selected. Background fluorescence (defined as the lowest fluorescence value in a neuron free region of the field) was subtracted from images, and fluorescence measurements for each cell (F x ) were normalized to the average fluorescence intensity of the 10 min baseline recording (F 0 ) to track normalized fluorescence (F x /F 0 ) over time. F x /F 0 of each cell from the field was averaged to produce one value, constituting one repetition of an experiment. and kept in the dark for additional 30 min at room temperature to deesterify indicators prior to imaging (using a green FITC fluorescence cube). Mitochondrial membrane potential (ΔΨ m ) was assessed by examining fluorescence changes in Rhod123 (Ex: 507 nm, Em: 529 nm), a positively charged dye that accumulates in active mitochondria, where its fluorescence intensity is quenched. Upon loss of ΔΨ m , Rhod123 is released into the cytosol, resulting in increased fluorescence (Duchen et al., 2003) . Neurons were incubated in the dark with 2 μM of Rhod123 in 1.8 Ca 2+ HSS for 30 min in room temperature prior to imaging (using a green FITC fluorescence cube). At the end of each experiment, the mitochondrial protonophore FCCP was added (1 μM, 5 min) to induce maximal loss of ΔΨ m (and record the corresponding maximal Rhod123 ΔF). ROS generation was assessed using the superoxide sensitive dye HEt (Ex: 510-560 nm; Em: > 590 nm; using a red TRITC fluorescence cube). Cultures were loaded in the dark at room temperature with 5 μM HEt in either 0 or 1.8 Ca 2+ HSS for 30 min prior to imaging; ROS production is assessed as the rate of fluorescence increase (HEt ΔF) as the HEt is oxidized into highly fluorescent ethidium.
Confocal imaging of mitochondrial morphology
Confocal microscopy of mitochondrial morphology was performed using an inverted stage Nikon Eclipse Ti chassis microscope with a Yokogawa CSUX spinning disk head. Images were collected with a 1000× (1.49 numerical aperture) oil-immersion objective using a Hamamatsu electromultiplying CCD camera, scanned sequentially with excitation (488 nm) via a Coherent sapphire laser source synchronized with the camera, and emission monitored with a 525 (50) nm filter, and acquired using MicroManager Image Acquisition software (version 1.4.16 Fig. 6 ). Acquired images were blinded to both treatment groups and time points, then imported into ImageJ software, which was used to make adjustment to whole image to provide optimal discrimination of mitochondrial morphology. Lengths and width of distinct mitochondria were measured manually, the values of which were then used to calculate the length/width (L/W) ratio of the mitochondria. To assess relative changes in morphology over time, the L/W ratio was normalized to baseline values. The L/W ratios of the mitochondria found in the selected field were averaged to produce one average L/W ratio, representing one repetition of an experiment.
Mitochondrial respiration assay
Mitochondrial respiration was assessed by measuring changes in O 2 consumption rate (OCR) using the Seahorse XF24 Extracellular Flux Analyzer, as described previously with adjustments (Yao et al., 2009 Fig. 7 ), washed into XF Base Medium (supplemented with 2 mM glutamine, 15 mM glucose, and 1 mM sodium pyruvate), and maintained at 37°C for 1 h. After the 1 h incubation, the cultures were placed in the Seahorse XF24 instrument, which measures the OCR of cells during baseline and after the sequential exposure to 1 μM oligomycin, 2 μM FCCP, and antimycin A/ rotenone (both at 1 μM). The concentrations of oligomycin, FCCP, and antimycin A/rotenone were based on those from the literature (Yao et al., 2009 ) as well as empirical titration, with FCCP specifically adjusted to induce at least 1.5× the baseline OCR. Prior to each experiment, Seahorse XF24 instrument was calibrated following the manufacturer's protocols, and all culture wells were visually inspected (to ensure equal distribution of cells) and randomly assigned to treatment groups. Seahorse XF24 program was used to run the assay and Seahorse Wave Software used to analyze data. As neurons were plated on preestablished astrocyte monolayers (using the same culturing methods as described above), we carried out validation studies comparing responses of neuron-astrocyte co-culture to those of astrocyte-only cultures, confirming that astrocytes made minimal (≤ 5%) contributions to observed basal OCR and OCR changes (data not shown).
Assessment of cell death
Cell death was assessed in neurons plated on culture treated 24 well microplates. Briefly, 14-16 DIV neurons were switched into 0 or 1.8 Ca 2+ HSS, and exposed to a combination of DTDP, TPEN, Ca 2+ and/or Zn 2+ (concentration and durations detailed below). Cultures were then washed into MEM supplemented with 25 mM glucose and kept at 37°C/ 5% CO 2 for 24 h (unless otherwise specified), prior to assessment of neuronal injury via direct examination (under phase-contrast microscopy) and by lactate dehydrogenase (LDH) efflux assay as described (Koh and Choi, 1987) . The small amount of background LDH present in the media of cultures carried though a sham-wash protocol was subtracted from values obtained in treated cultures. In each experiment, LDH values were scaled to the mean value obtained by a standard exposure to 300 μM NMDA for 24 h (an exposure that reliably destroys most of the neuronal population without glial damage).
Statistical analysis and repetition
To assess significance, either two-tailed t-test or one-way ANOVA with Tukey post-hoc analysis (indicated in each figure legend) was used, depending on the number of groups of comparison. All values are displayed as mean ± standard error of the mean (SEM). All experiments were repeated at least 3 times. Note that because of some differences in precise behavior of batches of cells reflecting biologic variables-including age and health-all comparisons reflect matched sets of cells, using the same sets of culture dissections with interleaved experiments. (Clausen et al., 2013; Jiang et al., 2001; Sensi et al., 2003; Sensi et al., 2002; Sensi et al., 2000) . While mitochondrial Ca 2+ accumulation has long been considered the major contributor to their dysfunction in ischemia (Halestrap, 2006; Nicholls and Budd, 2000) , clues have emerged that Zn 2+ may also be an important contributor (Bonanni et al., 2006; Calderone et al., 2004; Medvedeva et al., 2017; Medvedeva et al., 2009; Medvedeva and Weiss, 2014) , particularly after rapid influx through highly Zn 2+ permeable Ca-AMPA channels (Jia et al., 2002; Sensi et al., 1999a; Yin and Weiss, 1995) . However, although brief exposure of cultured neurons to Zn 2+ under depolarizing conditions (triggering entry largely through VSCC) led to considerable delayed degeneration (Weiss et al., 1993) , this induced only mild acute effects on mitochondria (Pivovarova et al., 2014; Sensi et al., 1999a) Newport Green (K d~1 μM) (Sensi et al., 1999a) in 0 Ca 2+ HSS (to ensure observation of Zn 2+ -specific effects). After measuring baseline fluorescence for 10 min, cultures were exposed to 25, 75, or 300 μM Zn 2+ with high (90 mM) K + for 5 min, washed into 0 Ca 2+ HSS for 5 min, then treated to the mitochondrial protonophore, carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP, 1 μM) for 10 min. FCCP dissipates the proton gradient across the inner mitochondrial membrane, resulting in rapid loss of mitochondrial membrane potential (ΔΨ m ) and release of mitochondrially sequestered Zn 2+ (Clausen et al., 2013; Medvedeva et al., 2017; Sensi et al., 2003; Sensi et al., 2002 (Duchen et al., 2003) . ROS generation was assessed using the superoxide preferring oxidant sensitive indicator, hydroethidine (HEt), which is oxidized by superoxide radicals into the highly fluorescent compound, ethidium. The fluorescence of ethidium is amplified upon its binding to DNA, providing high sensitivity and resulting in predominant visualization of the signal in the nucleus (Bindokas et al., 1996) . Because the oxidized ethidium accumulates, the rate of fluorescence increase indicates ROS production rate, and the increase in HEt fluorescence (HEt ΔF) over baseline reflects total ROS production. (Noh and Koh, 2000) , our prior studies indicated that rapid Zn 2+ triggered ROS production is almost entirely of mitochondrial origin (Clausen et al., 2013; Sensi et al., 1999a and preventing the released Zn 2+ from being bound again (Aizenman et al., 2000; Maret and Vallee, 1998; Sensi et al., 2003) . To assess Zn 2+ release from the buffers and its ability to enter mitochondria, we loaded cells (in 0 Ca 2+ HSS) with the higher affinity Zn 2+ indicator, FluoZin-3 (K d~1 5 nM) (Gee et al., 2002; Sensi et al., 2003) , and monitored changes in fluorescence before and after application of 100 μM DTDP and subsequent addition of FCCP. In agreement with our prior observations (Sensi et al., 2003) , this fairly high DTDP exposure caused a prompt but relatively modest Zn 2+ rise, followed by a further sharp rise in cytosolic Zn 2+ upon FCCP exposure, indicating robust mitochondrial Zn 2+ accumulation (likely due to strong disruption of cytosolic buffering). With lower (60 μM) DTDP, we still observed an acute cytosolic Zn 2+ rise and mitochondrial Zn 2+ uptake, but these were markedly diminished, consistent with impaired-but not fully disrupted-Zn 2+ buffering ( Fig. 2A) .
Results
Slow
To examine acute effects of these DTDP exposures on mitochondria, we used the ΔΨ m indicator Rhod123 and the ROS indicator HEt, as above. With continuous exposure to 100 μM DTDP, we noted a gradual increase in Rhod123 ΔF that progressed to subtotal loss of Δψ m within 40 min (as indicated by lack of response to FCCP), and a rise in HEt ΔF indicative of increased ROS production. In contrast, with 60 μM DTDP, there was little Rhod123 or HEt ΔF (Fig. 2B) Fig. 1 ), we found these exposures to induce similar cytosolic rises and levels of acute mitochondrial Zn 2+ accumulation (as indicated by the similar Newport Green ΔF upon adding FCCP; Fig. 3A ), but the combined exposure caused markedly greater loss of Δψ m and ROS generation than the higher Zn 2+ exposure alone (Fig. 3B, C) .
Furthermore, the loss of Δψ m and ROS generation occurring after the high K + /50 μM Zn 2+ /DTDP exposure are not transient, but appeared to progress at a near constant rate (as indicated by the slope of the Rhod123 and HEt ΔF traces) for the duration of the recording period. Prior studies have estimated that peak cytosolic Zn 2+ rises after brief exposure to high K + /300 μM Zn 2+ are in the 100 s of nM (a substantial increase from subnanomolar resting levels) (Canzoniero et al., 1999; Colvin et al., 2010; Frederickson et al., 2005; Maret, 2015; Sensi et al., 1999a 4A ) and greater acute effects on Δψ m and ROS generation (Fig. 4B, C) . Interestingly, the difference was greater for the ROS generation, with both exposures only causing partial loss of Δψ m . . In addition, as NOX activation has been reported to contribute, along with mitochondria, to acute Ca 2+ triggered ROS generation (unlike acute Zn 2+ triggered ROS, which, as discussed above, appears mostly to be of mitochondrial origin) (Brennan et al., 2009; Clausen et al., 2013) , the NOX inhibitor apocynin (500 μM) was added in HEt loaded cultures to prevent ROS generation due to Ca 2+ dependent activation of this enzyme. While the high K + exposures with either the 10 μM Zn 2+ or 1.8 mM Ca 2+ alone had little acute impact on the mitochondria, the combined exposure resulted in substantially greater loss of Δψ m and ROS generation (Fig. 5B) , further substantiating the synergistic effects of Ca 2+ and Zn 2+ on mitochondria.
Finally, we examined the dose dependence of loss of Δψ m and ROS generation at the high end of the exposure range, in light of our prior observations (Fig. 4B, C) (Brustovetsky et al., 2002; Halestrap, 2006; Jiang et al., 2001; Sugawara et al., 1999) . To assess mitochondrial morphology, cultures were loaded with the fluorescent mitochondrial marker, MitoTracker Green (200 nM), and neuronal mitochondria examined using confocal microscopy at 1000× (as described in Material and methods). This marker has the advantages that it covalently binds to mitochondrial proteins (and thus stays in neuronal mitochondria despite loss of Δψ m ) and maintains fluorescence in oxidative environments (Buckman et al., 2001; Jiang et al., 2001 ). Cultures were exposed as indicated to high K + /MK-801 with Zn 2+ and/ or Ca 2+ ( ± DTDP) and images acquired at baseline, after the 5 min Zn 2+ /Ca 2+ exposure, and, finally, 10 min after wash (into HSS ± DTDP) (as indicated in Fig. 6A, B) . We examined effects of 60 μM as well as 100 μM DTDP, to assess possible consequences of Zn 2+ loads with both partial and near maximal disruption of cytosolic buffering, as might occur during episodes of strong in vivo ischemia. To assess morphological changes, images were blinded to experimental condition and time point, and imported into Image J software, where the lengths and widths of distinct mitochondria were measured manually (see Material and methods); data are expressed as mean length/width (L/W) ratios normalized to baseline values (which ranged from 4 to 8; mean 5.9 ± 0.3). There were distinct differences triggered by the different exposures ( Fig. 6C) appears to be strongly progressive after termination of the exposure. We next sought to examine delayed effects of the Zn 2+ exposures on mitochondrial respiration. Indeed, as the main function of mitochondria is energy production, which is dependent upon the integrity of the electron transport chain, we felt it critical to assess such effects, which, in contrast to loss of Δψ m and ROS production, provide a direct measure of the disruption of mitochondrial respiratory capacity after an insult. For these studies, we made use of a device (the Seahorse XF24 analyzer) which measures the O 2 consumption rate (OCR) in cultures at baseline and in response to sequential application of the following drugs: (1) the ATP synthase inhibitor, oligomycin (1 μM), which prevents dissipation of the proton gradient across the inner membrane due to ATP synthesis, leading to membrane hyperpolarization and slowing of electron transport; the decrease in OCR upon its application provides an estimate of the portion of O 2 consumption contributing to ATP production; (2) FCCP (2 μM), which dissipates the proton gradient, uncoupling the electron transport chain, yielding maximal oxidative capacity and OCR, and; (3) combined application the complex I blocker, rotenone, and the complex III blocker, antimycin A (both 1 μM), to fully inhibit the electron transport chain, and blocking all mitochondrial respiration ( Fig. 7A ) (Brand and Nicholls, 2011 -triggered mitochondrial dysfunction may be irreversible and contribute to neuronal death in pathological conditions.
Mitochondrial Zn
2+ accumulation contributes to dose-dependent cell death While above studies showing pronounced mitochondrial swelling and long lasting respiratory inhibition might predict that these effects would contribute to subsequent neurodegeneration, they are not in themselves indicative of cell death. We thus felt it important to carry out neurotoxicity studies, to more directly address the cytotoxic consequences of the mitochondrial effects (Fig. 8) .
Two sets of studies-generally paralleling those on mitochondrial respiration (Fig. 7) -were carried out to assess the importance of both Zn 2+ -Ca 2+ synergy and integrity of cytosolic Zn 2+ buffering to delayed neurodegeneration. In the first set, cultures were exposed to high K + / MK-801 with 300 μM Zn 2+ , 1.8 mM Ca 2+ , or both Zn 2+ and Ca 2+ for 5 min (Fig. 8A ). In the second set, cultures were pre-exposed to 100 μM DTDP prior to 5 min high K + /MK-801 with 0, 50 or 100 μM Zn 2+ ( ± Ca 2+ ), followed by 10 min washout into DTDP (Fig. 8B) . In both sets, neurons were transferred to MEM (supplemented with 25 mM glucose) and returned to the incubator for 24 h after which neuronal injury was assessed via direct morphological examination and by lactate dehydrogenase (LDH) efflux assay (as described in Material and methods). despite both inducing similar levels of ROS generation. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.) Weiss Experimental Neurology 302 (2018) 181-195 strongly disrupted buffering (Fig. 8A, B) . While these findings do not directly prove that Zn 2+ induced mitochondrial dysfunction caused the cell death, the similarity of effects for both mitochondrial dysfunction and neurodegeneration strongly suggest a link between the two. In addition, to examine the temporal relationship between mitochondrial disruption and cell death (as indicated by LDH release, reflecting loss of membrane integrity), cultures were pre-exposed to 100 μM DTDP prior to 5 min high K + /MK-801 with 50 μM Zn 2+ + Ca 2+ followed by 10 min washout into DTDP (as in Fig. 8B ), but with LDH release measured after both 2 h (when we observed near complete inhibition of respiration, see Fig. 7C ) and after 24 h. We found the LDH release at 2 h to be less than half that at 24 h, highlighting the progressive cellular disintegration occurring after severe mitochondrial disruption (Fig. 8C) . If mitochondrial Zn 2+ accumulation does contribute to neurodegeneration in vivo (such as after transient ischemia), it would be valuable to determine whether targeted delayed interventions could abrogate its effects, yielding better outcomes. To begin to address this possibility, we used the membrane permeable Zn 2+ chelator TPEN.
Cultures were subjected to an exposure we had found to cause rapid mitochondrial swelling and extensive neurodegeneration (high K + / 50 μM Zn 2+ /100 μM DTDP/MK-801 in 1.8 Ca 2+ HSS, with apocynin added in HEt loaded cultures, as in Figs. 6, 8B). We first examined effects of this exposure on ROS generation, which can contribute to subsequent neuronal damage. This exposure caused a rapidly increasing HEt ΔF that persisted for at least 30 min after the 5 min Zn 2+ exposure (much as in Fig. 5C ). However, when TPEN (20 μM) was added immediately after washout of the high K + /Zn 2+ exposure, the HEt ΔF was markedly attenuated (Fig. 9A) . We then wondered whether this attenuation of ROS generation would be reflected by changes in subsequent neurodegeneration. To test this, cultures were exposed to high K + /50 μM Zn 2+ /100 μM DTDP/MK-801 in 1.8 Ca 2+ HSS alone (as above; Fig. 8B ) or with TPEN (10 μM) added either 10 min before, during and after the Zn 2+ exposure (TPEN pre-treatment), or only after the Zn 2+ exposure (TPEN post-treatment; Fig. 9B ). While TPEN pre-treatment was markedly protective, validating the importance of Zn 2+ to neuronal injury, it is notable that post-treatment was also modestly protective (Fig. 9B) . As the effect of Zn 2+ chelation on cell death parallels that on ROS generation (Fig. 9A) , these findings further support the idea that mitochondrial dysfunction contributes to neurodegeneration and suggest the potential utility of delayed interventions. In sum, these findings not only strengthen the hypothesis that slow Zn 2+ translocation via VSCC along with Ca
2+
, under conditions of disrupted cytosolic Zn 2+ buffering (as likely occurs during pathologic conditions), can induce mitochondrial dysfunction and cell death, but also suggest the exciting possibility that delayed modulation of mitochondrial Zn 2+ accumulation could provide neuroprotection. where indicated), high K + /MK-801 with Zn 2+ (0, 50, or 300 μM) and/or 1.8 mM Ca 2+ , followed by wash into HSS ± DTDP, as described. B). Representative images: Confocal images (1000×) were taken at baseline, 5 min after Zn 2+ and/or Ca 2+ exposure, and 10 min after wash.
C). Zn 2+ and Ca 2+ induce different patterns of morphology change: The length and width of individual mitochondria were measured blindly, and length/width (L/W) ratios calculated and normalized to baseline. Values for baseline, 5 min after exposure, and after 10 min wash are displayed. Traces show mean ± SEM normalized L/W ratio for each time point, each representing ≥5 experiments consisting of ≥50 mitochondria (* indicates p < .05, ** indicates p < .01, by one-way ANOVA with Tukey post hoc). Note that while the Ca 2+ induces a rapid but transient morphologic change, Zn 2+ triggers more progressive changes (that increase with the degree of Zn 2+ loading).
Discussion
Summary of findings
In the present study, we sought to elucidate effects of slow Zn 2+ uptake via VSCC on mitochondrial function and subsequent neuronal injury. We find that with disrupted buffering, as likely occurs during in vivo ischemia, brief exposure to low Zn 2+ under depolarizing conditions (to elicit extracellular Zn 2+ entry through the VSCC) induced acute mitochondrial dysfunction, including loss of ΔΨ m , ROS generation, mitochondrial swelling, and inhibition of respiration, as well as delayed neurodegeneration. The presence of physiologic levels of Ca 2+ exacerbated these deleterious Zn 2+ effects despite attenuating both cytosolic and mitochondrial Zn 2+ accumulation, suggesting strong synergism between these ions. While our findings do not prove that Zn 2+ triggered mitochondrial dysfunction directly led to neurodegeneration, the strong correlation between the effects of Zn 2+ exposures under varied conditions on mitochondria with the induction of cell death supports the hypothesis that mitochondrial Zn 2+ accumulation-and the consequent dysfunction-is an important upstream contributor to neuronal injury. Finally, Zn 2+ chelation after Zn 2+ loading attenuated both mitochondrial ROS generation and neuron death, further (Calderone et al., 2004; Koh et al., 1996; Tonder et al., 1990) . Indeed, most Ca 2+ indicators also respond to Zn 2+ with greater affinity than Ca 2+ , and it is likely that some effects previously attributed to Ca 2+ are actually due to Zn 2+ (Cheng and Reynolds, 1998; Stork and Li, 2006) . Our understanding of Zn 2+ mechanisms in ischemia has been in flux. It was first assumed that the toxic Zn 2+ accumulation seen after ischemia or prolonged seizures resulted from presynaptic release (Assaf and Chung, 1984; Howell et al., 1984) and its translocation into postsynaptic neurons (Koh et al., 1996; Tonder et al., 1990 ) through routes including VSCC and Ca-AMPA channels (Noh et al., 2005; Sensi et al., 2000; Yin et al., 2002) . However, in studies using mice lacking presynaptic releasable Zn 2+ (via knockout of the vesicular Zn 2+ transporter, ZnT3) Cole et al., 1999) , prolonged seizures surprisingly still caused strong Zn 2+ accumulation and Zn 2+ dependent injury to CA1 pyramidal neurons, highlighting critical contributions from other sources (Lee et al., 2000) . Further studies using ZnT3 knockouts as well as knockouts of the neuronal Zn 2+ binding protein, metallothionein-III (MT-III) (Erickson et al., 1997) , provided compelling evidence for distinct contributions of Zn 2+ to neuronal injury between CA1 and CA3 pyramidal neurons, with Zn 2+ translocation, likely in large part through Ca-AMPA channels, predominating in CA3, but mobilization from MT-III predominating in CA1 (Lee et al., 2000; Lee et al., 2003; Medvedeva et al., 2017) . Thus, it is now apparent that synaptically released Zn 2+ as well as Zn 2+ mobilized from intracellular binding proteins (like MT-III) can contribute to neuronal accumulation and injury in pathological conditions, although the respective contributions from these sources likely differ between populations of neurons. Another unsettled question concerns the target(s) through which Zn 2+ mediates injury. While it is apparent that Zn 2+ can activate multiple pathways that contribute to neurodegeneration (Shuttleworth and Weiss, 2011) , several lines of evidence led us to consider that mitochondria may be an important early target. Zn 2+ has potent and complicated effects on isolated mitochondria, entering them through the mitochondrial Ca 2+ uniporter (MCU), inhibiting electron transport and other critical mitochondrial enzymes at submicromolar concentrations, and triggering swelling via activation of mitochondrial permeability transition pore (mPTP); highlighting the complexity of these effects, they are exposure dependent, with low levels increasing respiration and inhibiting ROS production while high levels induced opposite effects (Brown et al., 2000; Dineley et al., 2005; Gazaryan et al., 2007; Jiang et al., 2001; Link and von Jagow, 1995; Sensi et al., 2003; Skulachev et al., 1967; Wudarczyk et al., 1999) . In cultured neurons, Zn 2+ loading via rapid entry through Ca-AMPA channels resulted in acute mitochondrial dysfunction, including rapid loss of Δψ m and ROS production (Sensi et al., 1999a; Sensi et al., 1999b Sensi et al., , 2000 , supporting the idea that mitochondria may be important Zn 2+ targets in neuronal injury. However, not all studies support this idea. First, brief fairly high (300 μM) Zn 2+ exposures to depolarized neurons (triggering slower Zn 2+ translocation through VSCC) induced considerable delayed neurodegeneration but caused relatively little acute mitochondrial dysfunction (Pivovarova et al., 2014; Sensi et al., 1999a; Weiss et al., 1993) . Furthermore, a recent study on isolated mitochondria in highly purified Ca 2+ free buffer reported that in contrast to Ca 2+ , Zn 2+ was a weak trigger of depolarization and did not trigger mPTP opening (Devinney et al., 2009 (Medvedeva et al., 2009) , with uptake of endogenous Zn 2+ into mitochondria through the MCU contributing specifically to ROS production and neuronal cell death (Medvedeva and Weiss, 2014) . Indeed, other studies have supported the idea that Zn 2+ may contribute to mitochondrial dysfunction after in vivo ischemia, specifically promoting release of pro-apoptotic peptides from mitochondria and contributing to the activation of large channels in the mitochondrial outer membranes (Bonanni et al., 2006; Calderone et al., 2004 ). As noted above, despite some studies suggesting that Zn 2+ may only weakly impact mitochondrial function (Devinney et al., 2009; Pivovarova et al., 2014) , there has been a growing body of evidence that Zn 2+ -as well as Ca 2+ -can enter mitochondria and impact their function. While the nature of interactions between these ions on mitochondria has been little explored, prior studies have provided early clues for possible synergism between these ions. Specifically, combined application of Ca 2+ and Zn 2+ caused greater swelling of isolated mitochondria than Ca 2+ or Zn 2+ alone (Jiang et al., 2001) , and Zn 2+ entry through Ca-AMPA channels yielded stronger and more persistent ROS generation when Ca 2+ was also present . Present studies extend these early clues via examination of effects of slower Zn 2+ and Ca 2+ entry through VSCC, and find potent synergism be- remains unclear and merits further study. One possibility is that the presence of Ca 2+ may modify Zn 2+ permeation through the MCU.
While the MCU was previously considered to be quite selective for Ca 2+ , Zn 2+ can also enter mitochondria through this route (Clausen et al., 2013; Gazaryan et al., 2007; Jiang et al., 2001; Malaiyandi et al., 2005; Saris and Niva, 1994) , and Ca 2+ was actually found to markedly facilitate Zn 2+ entry through the MCU in isolated mitochondria (Saris and Niva, 1994) . Studies of the recently identified MCU protein and associated regulatory peptides may yield further clues, with two peptides (termed MICU1 and MICU2) acting to regulate pore conductance as a function of the cytosolic Ca 2+ concentration, inhibiting the channel when levels are low, and activating it when they rise (Kamer and Mootha, 2015; Marchi and Pinton, 2014; Murgia and Rizzuto, 2015 (Pivovarova et al., 2014; Sensi et al., 1999a) . However, although such relatively slow Zn 2+ entry through VSCC does not cause the acute ROS production and strong loss of ΔΨ m seen with more rapid entry (through Ca-AMPA channels), these exposures do result in persistent (at least 2 h) Zn 2+ accumulation in mitochondria, contributing to partial loss of ΔΨ m and release of pro-apoptotic peptides (Jiang et al., 2001; Sensi et al., 2002) . It is also notable that strong disruption of cytosolic Zn 2+ buffering alone (in the absence of extracellular Zn
2+
) results in sufficient intracellular Zn 2+ mobilization to cause milder disruption of mitochondrial function and trigger delayed neurodegeneration (Aizenman et al., 2000; Bossy-Wetzel et al., 2004; Sensi et al., 2003) . Thus, perhaps it is not surprising that in combination, even relatively slow Zn 2+ entry under conditions of impaired cytosolic Zn 2+ buffering can acutely disrupt mitochondrial function.
In past studies we found that strong disruption of buffering enhanced ROS production caused by relatively low levels of Zn 2+ entry (Clausen et al., 2013) . Present studies markedly extend the understanding of conditions that determine effects of cellular Zn 2+ loads on mitochondria. First, we find that even partial disruption of cytosolic Zn 2+ buffering (that had little effect on its own), markedly increase mitochondrial dysfunction caused by brief Zn 2+ exposures even at levels as low as 10 μM. Secondly, we find that the effects are markedly enhanced by the presence of physiological levels of Ca 2+ entry (and may be artificially inhibited under the non-physiological conditions of limited or absent Ca 2+ in which many prior studies of Zn 2+ were carried out). We further find that the enhanced disruption of mitochondria extends beyond the usual measures of loss of ΔΨ m and ROS production to include strong and progressive swelling and long lasting inhibition of respiration, effects that may be indicative of severe or irrecoverable disruption. Finally, we examine effects of the presence of Ca 2+ and disrupted Zn 2+ buffering on cell death. While we do not definitively demonstrate that the Zn 2+ dependent mitochondrial disruption leads directly to cell death, we found the effects on mitochondrial function to be strongly correlated with those on cell death and that delayed Zn 2+ chelation attenuated both the mitochondrial ROS generation and the subsequent neurodegeneration. Thus, our studies provide new support to the idea that Zn 2+ triggered mitochondrial disruption is an important upstream event that contributes to delayed injury, the targeting of which could be protective.
Conclusions and possible therapeutic implications
We started with the comment that the available treatments for ischemia injury are inadequate, reflecting in part incomplete understanding of relevant targetable events. We wish to end by suggesting a new hypothesis: Early mitochondrial Zn 2+ accumulation-and the consequent disruption of their function-is a critical and targetable event in the neurodegenerative sequence. The validity of this hypothesis depends upon a number of factors: 1. The occurrence of disrupted buffering. It is apparent that acidosis and oxidative stress occur in the context of ischemia, and can result in the disruption of cytosolic Zn 2+ buffering and its toxic accumulation in neurons (Aizenman et al., 2000; Lee et al., 2000; Sensi et al., 2003; Shuttleworth and Weiss, 2011; Weiss et al., 2000) . 2. The occurrence of Zn 2+ accumulation in the extracellular space. It is difficult to accurately quantify Zn 2+ accumulation in brain resulting from synaptic release; early estimates that peak levels reach 100-300 μM (Frederickson, 1989) are probably high. Widespread extracellular accumulation with ischemia or seizures certainly occurs, and recent studies suggest that levels in the 10-100 μM range may be achievable in areas of hippocampus and cortex where there is considerable synaptic Zn 2+ (Frederickson et al., 2006; Ueno et al., 2002; Vogt et al., 2000) . Although neurons expressing Ca-AMPA channels may get the strongest Zn 2+ loads, present studies suggest that even brief presence of as little as 10 μM Zn 2+ may result in sufficient entry into any depolarized neurons with impaired cytosolic Zn 2+ buffering to trigger acute mitochondrial disruption. In light of observations that VSCC activity increases with aging and chronic hypoxia Campbell et al., 1996; Webster et al., 2006) , these effects may be greater still in the aging populations most at risk of ischemic attack. Present studies also provide a "proof of principle" for the potential utility of delayed delivery of Zn 2+ targeting interventions -with Zn 2+ chelation after the Zn 2+ exposure decreasing both ROS generation and subsequent cell death (Fig. 9) , consistent with other recent findings on OGD induced ROS production (Slepchenko et al., 2017) . Optimal interventions may vary depending on when the intervention is delivered. In the early phases, interventions targeting Zn 2+ entry into mitochondria might include Zn 2+ chelators, MCU blockers, or antioxidants (to diminish oxidative disruption of buffering) while at later stages, mPTP blockers may decrease mitochondrial swelling and mediator release (Friberg and Wieloch, 2002) . Of note, most drugs have multiple effects complicating the development of optimal interventions. For instance, whereas MCU blockers alone in early stages of ischemia might diminish mitochondrial Zn 2+ accumulation, they could hasten injury by promoting cytosolic Ca 2+ overload (Medvedeva and Weiss, 2014; Velasco and Tapia, 2000) . We further suggest that consequences of mitochondrial Zn 2+ loading are variable; with very strong loads resulting in acute irreversible mitochondrial disruption and cell death (Medvedeva et al., 2009; Medvedeva and Weiss, 2014) , while milder ischemia may result in alterations in mitochondrial function that may contribute to the activation of downstream delayed cell death pathways. Recent findings are compatible with this idea. CA1 pyramidal neurons undergo selective delayed degeneration after transient ischemia, which is associated with delayed mitochondrial swelling and cytochrome C release (Sugawara et al., 1999) . Interestingly, in recent slice studies, we found persistent Zn 2+ accumulation in CA1 mitochondria after transient sublethal OGD (Medvedeva et al., 2017) . In light of the demonstrated potent ability of mitochondrial Zn 2+ to trigger dysfunction including ROS generation, swelling, mPTP activation and cytochrome C release (Gazaryan et al., 2007; Jiang et al., 2001; Weiss et al., 2000) might the Zn 2+ be a targetable trigger for the downstream death promoting events? One such mechanism may be the delayed insertion of Kv2.1 K + channels that can cause a form of apoptotic neurodegeneration (Aizenman et al., 2000; McLaughlin et al., 2001) . As mitochondrial ROS has been implicated in the activation of both p38 mitogen-activated protein kinase (MAPK) and apoptosis signal-regulating kinase 1 (ASK1) ( 
